STUYDING ON GENOTYPE AND ALLELE FREQUENCY OF CYP2E1*5B AND CYP2E1*7B POLYMORPHISM AT A VIETNAMESE GROUP LIVING IN THE NOTHERN PROVINCES

Bùi Thị Thu Hương; Nguyễn Phương Thảo; Nguyễn Thị Yến; Hoàng Thị Thu Yến

doi:10.34238/tnu-jst.6285

STUYDING ON GENOTYPE AND ALLELE FREQUENCY OF CYP2E15B AND CYP2E17B POLYMORPHISM AT A VIETNAMESE GROUP LIVING IN THE NOTHERN PROVINCES

About this article

Received: 21/07/22 Revised: 04/11/22 Published: 23/11/22

Authors

1. Bui Thi Thu Huong, TNU - University of Medicine and Pharmacy
2. Nguyen Phuong Thao, TNU - University of Sciences
3. Nguyen Thi Yen, TNU - University of Sciences
4. Hoang Thi Thu Yen , TNU - University of Sciences

Abstract

Cytochrome P450 family 2 subfamily E member 1 (CYP2E1) converts ethanol to acetaldehyde and reactive oxygen species that can cause liver damage and develope liver cancer in alcoholics. CYP2E1*5B T, CYP2E1*7B T of CYP2E1*5B (C-1053T; rs2031920/rs3813867) and CYP2E1*7B polymorphisms (G-71T; rs6413420) belong to the regulation region (5’-flanking region) is thought to enhance in CYP2E1 gene transcription. In this study, we determined allele and genotype frequency of CYP2E1*5B and CYP2E1*7B in 96 Vietnamese individuals for health checking and treatment at Thai Nguyen national hospital by identifying and nucleotide sequence analyzing. In 96 research individuals, 65 individuals were for the wild homozygous genotype CYP2E1*5B CC with the highest rate of 67.71%; 29 individuals with heterozygous genotype CYP2E1*5B CT ranked second, accounting for 30.21%, mutant homozygous genotype CYP2E1*5B TT has the lowest rate of 2.083% with 2 cases. The allele frequency of the mutant variant CYP2E1*5B T in the study population isn’t small (17.2%). While, CYP2E1*7B is not polymorphic, 100% of individuals have wild homozygous genotype CYP2E1*7B GG. Thus, ethanol metabolism in this study population was not affected by the CYP2E1*7B polymorphism, while CYP2E1*5B could have differences in the expression of the CYP2E1 gene. This study highlights the need to study the relationship of CYP2E1*5B polymorphisms in alcholism Vietnamese living in the northern provinces and suffer from related diseases.

Keywords

Alcohol abuse; Cytochrome P450 family 2 subfamily E member 1 (CYP2E1); CYP2E1*5B; CYP2E1*7B; rs6413420; rs2031920

Full Text:

PDF (Tiếng Việt)

References

[1] A. I. Cederbaum, "Alcohol metabolism," Clinics in liver disease, vol. 16, no. 4, pp. 667-685, 2012.

[2] P. J. Brooks and S. Zakhari, "Acetaldehyde and the genome: beyond nuclear DNA adducts and carcinogenesis," Environ Mol Mutagen, vol. 55, no. 2, pp. 77-71, 2014.

[3] S. I. Hayashi, J. Watanabe, and K. Kawajiri, "Genetic polymorphisms in the 5'-flanking region change transcriptional regulation of the human cytochrome P45011E1 gene," The Journal of Biochemistry, vol. 110, no. 4, pp. 559-565, 1991.

[4] J. S. A. Ramos, A. A. Alves, M. P. Lopes, T. M. A. Pedroso, L. P. Felício, W. F. Carvalho, F. C. Franco, C. O. A. Melo, M. W. Gonçalves, and T. N. Soares, "DNA damage in peripheral blood lymphocytes and association with polymorphisms in the promoter region of the CYP2E1 gene in alcoholics from Central Brazil," Alcohol, vol. 57, no. pp. 35-39, 2016.

[5] K. S. Fairbrother, J. Grove, I. de Waziers, D. T. Steimel, C. P. Day, C. L. Crespi, and A. K. Daly, "Detection and characterization of novel polymorphisms in the CYP2E1 gene," Pharmacogenetics, vol. 8, no. 6, pp. 543-552, 1998.

[6] B. N. Luu and T. T. Nguyen, Consumption of alcohol beverages in Viet Nam - Some national investigation results. National Economics University publishing company, Hanoi, p. 62, 2018.

[7] T. T. Y. Hoang and T. K. Nguyen, "Studying on allele frequency ADH1B*2 encoding alcohol dehydrogenase 1B at Vietnamese individuals living in Thai Nguyen City," TNU Journal of Science and Technology, vol. 226, no. 14, pp. 23-29, 2021.

[8] T. H. Nguyen, T. C. N. Do, P. H. Nguyen, T. H. V. Nguyen, P. T. Bui, and Q. H. Nguyen, "Genetic Polymorphism in Promoter Sequence of CYP2E1 Gene in Paint Manufacturing Workers Exposed to Volatile Organic Compounds," VNU Journal of science, vol. 34, no. 4, pp. 89-96, 2018.

[9] Q. Wei, Y. Ye, F. Chen, J. Li, H. Wu, Y. Fu, Y. Yan, and L. Liao, "Polymorphism study of nine SNPs associated with subjective response to alcohol in Chinese Han, Hui, Tibetan, Mongolian and Uygur populations," Forensic Sci Res, vol. 3, no. 2, pp. 124-129, 2018.

[10] T. Sugimura, H. Kumimoto, I. Tohnai, T. Fukui, K. Matsuo, S. Tsurusako, K. Mitsudo, M. Ueda, K. Tajima, and K. Ishizaki, "Gene–environment interaction involved in oral carcinogenesis: molecular epidemiological study for metabolic and DNA repair gene polymorphisms," J Oral Pathol Med, vol. 35, no. 1, pp. 11-18, 2006.

[11] N. Kongruttanachok, S. Sukdikul, S. Setavarin, V. Kerekhjanarong, P. Supiyaphun, N. Voravud, Y. Poovorawan, and A. Mutirangura, "Cytochrome P450 2E1 polymorphism and nasopharyngeal carcinoma development in Thailand: a correlative study," BMC cancer, vol. 1, no. 1, pp. 1-5, 2001.

[12] G. M. Shahriary, H. Galehdari, A. Jalali, F. Zanganeh, S. M. R. Alavi, and M. R. Aghanoori, "CYP2E1*5B, CYP2E1*6, CYP2E1*7B, CYP2E1*2, and CYP2E1*3 allele frequencies in Iranian populations," Asian Pac J Cancer Prev, vol. 13, no. 12, pp. 6505-6510, 2012.

[13] L. S. Binmahfouz and A. M. Bagher, "Genetic polymorphism of the drug-metabolizing enzyme Cytochrome P4502E1 (CYP2E1) in a healthy Saudi population," Saudi Pharm J, vol. 29, no. 11, pp. 1355-1360, 2021.

[14] S. Boccia, G. Cadoni, F. A. Sayed-Tabatabaei, M. Volante, D. Arzani, A. De Lauretis, C. Cattel, G. Almadori, C. M. Van Duijn, and G. Paludetti, "CYP1A1, CYP2E1, GSTM1, GSTT1, EPHX1 exons 3 and 4, and NAT2 polymorphisms, smoking, consumption of alcohol and fruit and vegetables and risk of head and neck cancer," J Cancer Res Clin Oncol, vol. 134, no. 1, pp. 93-100, 2008.

[15] S. Kunak, A. Ada, V. Karacaoglan, E. Soydas, S. Bilgen, and M. Iscan, "Drug/xenobiotic metabolizing enzyme polymorphisms in a Turkish population," Afr J Pharm Pharmacol, vol. 6, no. 27, pp. 2068-2074, 2012.

[16] M. Brocic, G. Supic, K. Zeljic, N. Jovic, R. Kozomara, S. Zagorac, M. Zlatkovic, and Z. Magic, "Genetic polymorphisms of ADH1C and CYP2E1 and risk of oral squamous cell carcinoma," Otolaryngol Head Neck Surg, vol. 145, no. 4, pp. 586-593, 2011.

[17] G. Korytina, O. Kochetova, L. Akhmadishina, E. Viktorova, and T. Victorova, "Polymorphisms of cytochrome p450 genes in three ethnic groups from Russia," Balkan Med J, vol. 2012, no. 3, pp. 252-260, 2012.

[18] A. Rossini, S. Soares Lima, D. Rapozo, M. Faria, R. Albano, and L. Ribeiro Pinto, "CYP2A6 and CYP2E1 polymorphisms in a Brazilian population living in Rio de Janeiro," Braz J Med Biol Res, vol. 39, no. 2, pp. 195-201, 2006.

[19] L. Quinones, D. Lucas, J. Godoy, D. Cáceres, F. Berthou, N. Varela, K. Lee, C. Acevedo, L. Martınez, and A. Aguilera, "CYP1A1, CYP2E1 and GSTM1 genetic polymorphisms. The effect of single and combined genotypes on lung cancer susceptibility in Chilean people," Cancer Lett, vol. 174, no. 1, pp. 35-44, 2001.

[20] X. Wu, H. Shi, H. Jiang, B. Kemp, W. K. Hong, G. L. Delclos, and M. R. Spitz, "Associations between cytochrome P4502E1 genotype, mutagen sensitivity, cigarette smoking and susceptibility to lung cancer," Carcinogenesis, vol. 18, no. 5, pp. 967-973, 1997.

[21] E. A. Stephens, J. A. Taylor, N. Kaplan, C.-H. Yang, L.L. Hsieh, G. W. Lucier, and D. A. Bell, "Ethnic variation in the CYP2E1 gene: polymorphism analysis of 695 African-Americans, European-Americans and Taiwanese," Pharmacogenetics, vol. 4, no. 4, pp. 185-192, 1994.

[22] E. Gordillo‐Bastidas, A. Panduro, D. Gordillo‐Bastidas, E. A. Zepeda‐Carrillo, J. J. García‐Bañuelos, J. F. Muñoz‐Valle, and B. E. Bastidas‐Ramírez, "Polymorphisms of alcohol metabolizing enzymes in indigenous Mexican population: unusual high frequency of CYP2E1* c2 allele," Alcohol Clin Exp Res, vol. 34, no. 1, pp. 142-149, 2010.

[23] S. Guaoua, I. Ratbi, F. Z. Laarabi, S. C. Elalaoui, I. C. Jaouad, A. Barkat, and A. Sefiani, "Distribution of allelic and genotypic frequencies of NAT2 and CYP2E1variants in Moroccan population," BMC genetics, vol. 15, no. 1, pp. 1-6, 2014.

[24] H. A. Basma, L. H. Kobeissi, M. E. Jabbour, M. A. Moussa, and H. R. Dhaini, "CYP2E1 and NQO1 genotypes and bladder cancer risk in a Lebanese population," Int J Mol Epidemiol Genet, vol. 4, no. 4, pp. 207, 2013.

[25] E.-U. Griese, K. F. Ilett, N. R. Kitteringham, M. Eichelbaum, H. Powell, R. M. Spargo, P. N. LeSouef, A. W. Musk, and R. F. Minchin, "Allele and genotype frequencies of polymorphic cytochromes P4502D6, 2C19 and 2E1 in aborigines from western Australia," Pharmacogenet Genomics, vol. 11, no. 1, pp. 69-76, 2001.

[26] Z. Kayaaltı and T. Söylemezoğlu, "Distribution of ADH1B, ALDH2, CYP2E1∗6, and CYP2E1∗7B genotypes in Turkish population," Alcohol, vol. 44, no. 5, pp. 415-423, 2010.

[27] T. Neuhaus, Y.-D. Ko, K. Lorenzen, S. Fronhoffs, V. Harth, P. Bröde, H. Vetter, H. M. Bolt, B. Pesch, and T. Brüning, "Association of cytochrome P450 2E1 polymorphisms and head and neck squamous cell cancer," Toxicology letters, vol. 151, no. 1, pp. 273-282, 2004.

DOI: https://doi.org/10.34238/tnu-jst.6285

Refbacks

There are currently no refbacks.



Remember me